BAY-069 - ≥99% , CAS No.2639638-66-5

CAS: 2639638-66-5 Cat. No.: B651866 Formule: C₂₂H₁₄ClF₃N₂O₃ Poids moléculaire: 446.81

QUALITÉ & PURETÉ ≥99%

Storage

Store at -20°C

Shipped In

Ice chest + Ice pads

Vue d’ensemble

BAY-069 is a potent branched-chain amino acid transaminases 1 (BCAT1) and BCAT2 inhibitor with IC 50 values of 31 nM and 153 nM, respectively. BAY-069 also can be used as a chemical probe. BAY-069 can be used tor research anticancer

In Vitro

BAY-069 (compound 36a) (70 nM-50 μM; 72 h) inhibits cell proliferation of U-87 and MDA-MB-231. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Proliferation AssayCell Line: U-87 and MDA-MB-231 Concentration: 70 nM-50 μM Incubation Time: 72 h Result: Inhibited cell proliferation of U-87 and MDA-MB-231 with IC 50 s of 358 nM and 874 nM, respectively.

In Vivo

BAY-069 exhibits high metabolic stability after incubation with human liver microsomes (CL blood = 0.11 L/h/kg) and moderate metabolic stability after incubation with rat hepatocytes (CL blood = 1.8 L/h/kg); shows high permeability through Caco-2 cell monolayers with no hint of efflux . BAY-069 (0.3 mg/kg for i.v.; 0.6 mg/kg for p.o.; single dosage) exhibits a favorable pharmacokinetic profile after i.v. dosing with low blood clearance (CL blood ), moderate volume of distribution at steady state (V ss ), and intermediate terminal half-life (t 1/2 ). MCE has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model: Male Wistar rats Dosage: 0.3 mg/kg for i.v.; 0.6 mg/kg for p.o. Administration: i.v. or p.o.; single dosage Result: Pharmacokinetic Parameters of BAY-069 in male Wistar rats . CL blood (L/h/kg) V ss (L/kg) t 1/2 (h), i.v. AUC norm (kg·h/L), i.v. AUC norm (kg·h/L), p.o. F (%), p.o. 0.64 0.25 1.6 2.9 2.5 89

Form:Solid

IC50& Target:IC 50 : 31 nM (BCAT1), 153 nM (BCAT2)

Spécifications

Spécifications et pureté

≥99%

Mécanismes biochimiques et physiologiques

BAY-069 is a potent branched-chain amino acid transaminases 1 (BCAT1) and BCAT2 inhibitor with IC 50 values of 31 nM and 153 nM, respectively. BAY-069 also can be used as a chemical probe. BAY-069 can be used tor research anticancer.

Conditions de stockage de stockage

Store at -20°C

Expédié en

Ice chest + Ice pads

Ce produit nécessite l'expédition en chaîne froide. Les services terrestres et autres services économiques ne sont pas disponibles.

Pureté

≥99%

Noms et identifiants

Sourires canoniques

CC(C=CC=C1)=C1OC2=C(Cl)C3=C(C=CC=C3)C(N4C(NC(C(F)(F)F)=CC4=O)=O)=C2

Poids moléculaire

446.81

Propriétés chimiques et physiques

• Solubilité: DMSO : 200 mg/mL (447.62 mM; Need ultrasonic)